Peptide Cotransporter 1 in Intestine and Organic Anion Transporters in Kidney Are Targets of Interaction between JBP485 and Lisinopril in Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptide Cotransporter 1 in Intestine and Organic Anion Transporters in Kidney Are Targets of Interaction between JBP485 and Lisinopril in Rats

Published:2012 Issue:2 Volume:27 Page:232-241
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Guo Xinjin,Meng Qiang,Liu Qi,Wang Changyuan,Mao Qi,Sun Huijun,Peng Jinyong,Kaku Taiichi,Liu Kexin

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference30 articles.

1. The renal type H+/peptide symporterPEPT2: structure-affinity relationships;Biegel;Amino Acids,2006

2. Peptide Transporters: Structure, Function, Regulation and Application for Drug Delivery;Terada;Curr. Drug Metab.,2004

3. Pharmaceutical and pharmacological importance of peptide transporters;Brandsch;J. Pharm. Pharmacol.,2008

4. Intestinal transport of β-lactamantibiotics: analysis of the affinity at the H+/ peptide symporter (PEPT1), theuptake into Caco-2 cell monolayers and the transepithelial flux;Bretschneider;Pharm. Res.,1999

5. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology;Daniel;Pflugers Arch.,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence;Clinical Pharmacology & Therapeutics;2020-05-10

2. Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence;2020-03-30

3. Current trends in drug metabolism and pharmacokinetics;Acta Pharmaceutica Sinica B;2019-11

4. Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes;Journal of Pharmaceutical Investigation;2019-04-12

5. Intestinal permeability determinants of norfloxacin in Ussing chamber model;European Journal of Pharmaceutical Sciences;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3